ExploreWatchlistsPricing
  1. JP-listed companies
  2. Fuso Pharmaceutical Industries,Ltd.
  3. Financials
  4. Net income margin (%)

Fuso Pharmaceutical Industries,Ltd. (4538)

Market cap
¥21.8B
P/E ratio
8.6x
Fuso Pharmaceutical Industries manufactures injectable medicines like intravenous solutions and kidney dialysis products, while also operating real estate leasing.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 2025-5.4-318.45%
Mar 31, 20242.5-21.01%
Mar 31, 20233.1+5.29%
Mar 31, 20223-8.42%
Mar 31, 20213.3+116.46%
Mar 31, 20201.5-22.31%
Mar 31, 20191.9-8.18%
Mar 31, 20182.1+14.82%
Mar 31, 20171.8+8320.43%
Mar 31, 20160-96.98%
Mar 31, 20150.7-82.07%
Mar 31, 20144-59.80%
Mar 31, 201310+1570.59%
Mar 31, 20120.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat